Skip to content

Biomarkers of health in exhaled breath of elderly people- a pilot study

Biomarkers of health in exhaled breath of elderly people- a pilot study - Breath study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON45259
Enrollment
100
Registered
2017-04-06
Start date
2017-05-23
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

asthma en irritable bowel syndrome) specific health complaints (diabetes mellitus type 2

Interventions

Breath analyses
Proton Transfer Reaction  Quadrupole ion Time Of Flight (PTR-QiTOF)
Seniors

Sponsors

Food and Biobased Research-Wageningen University & Research
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: Participants in all four groups must meet all of the following criteria: * They have signed the informed consent * They are * 55 years old * They are able and willing to visit the RIKILT lab facilities on a monthly basis (5 times in total). * They have a desktop or laptop with internet access at home ;Additional inclusion criteria per experimental subgroup (based on self reported information) * Diabetes mellitus type 2: formal diagnosis by a medical doctor * Asthma: formal diagnosis by a medical doctor , no exercise-induced asthma, prescribed medication use during the last month * Irritable bowel syndrom: formal diagnosis by a medical doctor and complaints during past month

Exclusion criteria

Exclusion criteria: * Smokers * People who suffer from more than one of the conditions of interest, diabetes type 2, asthma and/or irritable bowel syndrom

Design outcomes

Primary

MeasureTime frame
Degree of differentiation between biomarkers in seniors who either have no specific health complaints, or who suffer from either diabetes mellitus type 2, asthma, or irritable bowel syndrome.

Secondary

MeasureTime frame
Degree of association between the amount of measured biomarker and the severity of the specific health complaints.

Countries

The Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)